“Comparison of Outcomes of Linagliptin Plus Insulin and Insulin Only Among Type II Diabetes Mellitus Patients with Chronic Kidney Disease”, mfm, vol. 37, no. 3, Apr. 2026, doi: 10.60110/medforum.370314.